| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3284655 | Clinical Gastroenterology and Hepatology | 2008 | 7 Pages |
Abstract
In conclusion, immunostaining with newer protein markers is feasible in EUS-FNA specimens and can assist cytopathologists in diagnosing pancreatic cancer. Among the currently available protein immunomarkers, a combination of mesothelin and 14-3-3Ï seems most promising, but needs to be validated in prospective studies before routine clinical use.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Banke Agarwal, Olivia J. Ludwig, Brian T. Collins, Cherise Cortese,